药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Aprobarbital
Milnacipran
The risk or severity of hemorrhage can be increased when Milnacipran is combined with Edoxaban.
Aprobarbital
Alaproclate
The risk or severity of hemorrhage can be increased when Alaproclate is combined with Edoxaban.
Aprobarbital
Ritanserin
The risk or severity of hemorrhage can be increased when Ritanserin is combined with Edoxaban.
Aprobarbital
Indalpine
The risk or severity of hemorrhage can be increased when Indalpine is combined with Edoxaban.
Aprobarbital
Seproxetine
The risk or severity of hemorrhage can be increased when Seproxetine is combined with Edoxaban.
Aprobarbital
Dapoxetine
The risk or severity of hemorrhage can be increased when Dapoxetine is combined with Edoxaban.
Aprobarbital
Damoctocog alfa pegol
The therapeutic efficacy of Damoctocog alfa pegol can be decreased when used in combination with Edoxaban.
Aprobarbital
Calcium cation
The therapeutic efficacy of Calcium cation can be decreased when used in combination with Edoxaban.
Aprobarbital
Andexanet alfa
The therapeutic efficacy of Andexanet alfa can be decreased when used in combination with Edoxaban.
Aprobarbital
Beroctocog alfa
The therapeutic efficacy of Beroctocog alfa can be decreased when used in combination with Edoxaban.
Aprobarbital
Moroctocog alfa
The therapeutic efficacy of Moroctocog alfa can be decreased when used in combination with Edoxaban.
Aprobarbital
Nonacog beta pegol
The therapeutic efficacy of Nonacog beta pegol can be decreased when used in combination with Edoxaban.
Aprobarbital
Emicizumab
The therapeutic efficacy of Emicizumab can be decreased when used in combination with Edoxaban.
Aprobarbital
Trenonacog alfa
The therapeutic efficacy of Trenonacog alfa can be decreased when used in combination with Edoxaban.
Aprobarbital
Kallidinogenase
The therapeutic efficacy of Kallidinogenase can be decreased when used in combination with Edoxaban.
Aprobarbital
Antihemophilic factor human
The therapeutic efficacy of Antihemophilic factor human can be decreased when used in combination with Edoxaban.
Aprobarbital
Coagulation Factor IX Human
The therapeutic efficacy of Coagulation Factor IX Human can be decreased when used in combination with Edoxaban.
Aprobarbital
Anti-inhibitor coagulant complex
The therapeutic efficacy of Anti-inhibitor coagulant complex can be decreased when used in combination with Edoxaban.
Aprobarbital
Coagulation factor VII human
The therapeutic efficacy of Coagulation factor VII human can be decreased when used in combination with Edoxaban.
Aprobarbital
Coagulation factor X human
The therapeutic efficacy of Coagulation factor X human can be decreased when used in combination with Edoxaban.